VILIP-1 Downregulation in Non-Small Cell Lung Carcinomas: Mechanisms and Prediction of Survival
2008

VILIP-1 Downregulation in Non-Small Cell Lung Carcinomas

Sample size: 150 publication 10 minutes Evidence: high

Author Information

Author(s): Fu Jian, Fong Kathryn, Bellacosa Alfonso, Ross Eric, Apostolou Sinoula, Bassi Daniel E., Jin Fang, Zhang Jirong, Cairns Paul, de Caceres Inmaculada IbaƱez, Braunewell Karl-Heinz, Klein-Szanto Andres J.

Primary Institution: Fox Chase Cancer Center

Hypothesis

The study investigates whether genetic and epigenetic changes of the VILIP-1 gene in tobacco-associated human non-small cell lung carcinomas lead to protein expression alterations and affect clinical outcomes.

Conclusion

VILIP-1 expression is silenced by promoter hypermethylation and histone deacetylation in aggressive NSCLC cell lines and primary tumors, and its clinical evaluation could predict short-term survival in lung cancer patients.

Supporting Evidence

  • VILIP-1 expression was undetectable in 11 out of 12 NSCLC cell lines.
  • Hypermethylation of the VILIP-1 promoter was found to play a significant role in gene silencing.
  • Statistical analysis showed a significant relationship between promoter methylation and protein expression downregulation.
  • Patients with high VILIP-1 expression had significantly longer survival compared to those with low expression.

Takeaway

VILIP-1 is a protein that helps prevent cancer, but in many lung cancer patients, it is turned off due to changes in their DNA. This can make it harder for them to survive.

Methodology

The study involved analyzing VILIP-1 expression in NSCLC cell lines and primary tumors, assessing promoter methylation, and evaluating the relationship between VILIP-1 expression and patient survival.

Potential Biases

Potential bias in sample selection and the interpretation of immunohistochemistry results.

Limitations

The study primarily focused on a limited number of NSCLC samples and may not represent all lung cancer types.

Participant Demographics

The study included 81 NSCLC patients with clinical annotations and follow-up data.

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.0001

Digital Object Identifier (DOI)

10.1371/journal.pone.0001698

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication